This indefinite delivery contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Allucent Government Services (Us) LLC, a for-profit clinical research organization. The $550 million single-award IDC provides clinical trial planning and execution services in support of ASPR's medical countermeasure programs, including for chemical, biological, radiological, nuclear, pandemic influenza, and emerging infectious disease threats. Allucent has demonstrated capabilities across the clinical trial lifecycle, from preclinical through late-stage trials, as well as expertise in regulatory support, specimen management, and public health preparedness.
Under this IDC, Allucent has received several task orders for clinical trial services, including a $343.2 million award for planning and execution, a $34.1 million award for specimen collection, and smaller awards for clinical studies network support. The contract does not utilize any set-aside designations. The work is primarily performed at Allucent's facility in Houston, Texas. These task orders are part of ASPR's broader effort to establish a diverse pool of clinical research organizations to support the efficient development and testing of medical countermeasures through its Clinical Studies Network program.
Generated 9/13/24, 9:06 AM